David J Kuter (David Kuter)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Topics

Newly Diagnosed

Top Venues

British journal of haematology

American journal of hematology

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

David J Kuter, Jiří Mayer, Merlin Efraim, Lachezar H Bogdanov, Ross Ian Baker, Zane Kaplan, Mamta Garg, Marek Trněný, Philip Young-Ill Choi, Arend Jan Gerard Jansen, Vickie McDonald, Robert J Bird, Jaromir Gumulec, Milan Košťál, Terry Gernsheimer, Waleed Ghanima, Ahmed A Daak, Nichola Cooper
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia. Blood advances 8 (7) (2024)
David J Kuter, Umer Khan, Paul Maruff, Ahmed A Daak
Cognitive impairment among patients with chronic immune thrombocytopenia. British journal of haematology (2024)
David J Kuter, Jiří Mayer, Merlin Efraim, Lachezar H Bogdanov, Ross Ian Baker, Zane Kaplan, Mamta Garg, Marek Trněný, Philip Young-Ill Choi, Arend Jan Gerard Jansen, Vickie McDonald, Robert J Bird, Jaromir Gumulec, Milan Košťál, Terry Gernsheimer, Waleed Ghanima, Ahmed A Daak, Nichola Cooper
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia. Blood advances 8 (7) (2024)
David J Kuter, Jiri Mayer, Merlin Efraim, Lachezar H Bogdanov, Ross Ian Baker, Zane S Kaplan, Mamta Garg, Marek Trněný, Philip Young-Ill Choi, Arend Jan Gerard Jansen, Vickie McDonald, Robert J Bird, Jaromir Gumulec, Milan Košťál, Terry Gernsheimer, Waleed Ghanima, Ahmed Abd Almalik Daak, Nichola Cooper
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia. Blood advances (2024)
David J Kuter, Umer Khan, Paul Maruff, Ahmed A Daak
Cognitive impairment among patients with chronic immune thrombocytopenia. British journal of haematology 205 (1) (2024)
David J Kuter, Caroline Piatek, Alexander Röth, Asif Siddiqui, Robert P Numerof, Wolfgang Dummer, null null
Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double-blind, placebo-controlled, global study (FORWARD). American journal of hematology (2023)
Annemarie Erin Fogerty, David J Kuter
How I Treat Thrombocytopenia in Pregnancy. Blood (2023)
David J Kuter, James B Bussel, Waleed Ghanima, Nichola Cooper, Terry Gernsheimer, Michele P Lambert, Howard A Liebman, Michael D Tarantino, Michelle Lee, Hailing Guo, Ahmed Daak
Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study. Therapeutic advances in hematology 14 (2023)
Alexander Röth, Wilma Barcellini, Shirley D'Sa, Yoshitaka Miyakawa, Catherine M Broome, Marc Michel, David J Kuter, Bernd Jilma, Tor Henrik Anderson Tvedt, Ilene C Weitz, Ronnie Yoo, Deepthi Jayawardene, Deepthi S Vagge, Katarina Kralova, Frank Shafer, Marek Wardȩcki, Michelle Lee, Sigbjørn Berentsen
Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease. American journal of hematology (2023)
Waleed Ghanima, Quentin A A Hill, David J Kuter
ITP definitions: Time for an update. British journal of haematology (2023)
Anem Waheed, David J Kuter
Hematological support of patients with significant anemia who decline red blood cell blood transfusion. American journal of hematology 97 (11) (2022)
David J Kuter, Kerry A Rogers, Michael A Boxer, Michael Choi, Richy Agajanian, Donald M Arnold, Catherine M Broome, Joshua J Field, Irina Murakhovskaya, Robert Numerof, Sandra Tong
Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study. American journal of hematology 97 (6) (2022)
Catherine M Broome, Alexander Röth, David J Kuter, Marie Scully, Roy Smith, Jennifer Wang, Caroline Reuter, William Edward Hobbs, Ahmed Abd Almalik Daak
Safety and Efficacy of Classical Complement Pathway Inhibition with Sutimlimab in Chronic Immune Thrombocytopenia. Blood advances (2022)
David J Kuter
Exacerbation of immune thrombocytopenia following COVID-19 vaccination. British journal of haematology 195 (3) (2021)
David J Kuter
Novel therapies for immune thrombocytopenia. British journal of haematology (2021)
Anem Waheed, David J Kuter
Iron overload after complement inhibitor treatment of Paroxysmal Nocturnal Hemoglobinuria. American journal of hematology 96 (7) (2021)
Leah J McGrath, Carrie Nielson, Bradley Saul, Alexander Breskin, Ying Yu, Sia K Nicolaisen, Karynsa Kilpatrick, Waleed Ghanima, Christian Fynbo Christiansen, Shahram Bahmanyar, Marie Linder, Melissa Eisen, Jeffrey Wasser, Ivy Altomare, David J Kuter, Henrik T Sørensen, Michael Kelsh, M Alan Brookhart
Lessons Learned Using Real-World Data to Emulate Randomized Trials: A Case Study of Treatment Effectiveness for Newly Diagnosed Immune Thrombocytopenia. Clinical pharmacology and therapeutics 110 (6) (2021)
Andrew B Song, Katayoon Goodarzi, Rebecca Karp Leaf, David J Kuter, David J Kuter
Thrombopoietin level predicts response to treatment with romiplostim in chemotherapy-induced thrombocytopenia. American journal of hematology 96 (12) (2021)
Daniel T Mytych, Joseph K Park, June Kim, Troy E Barger, Andy Boshier, Vibha Jawa, David J Kuter
Assessment of romiplostim immunogenicity in adult patients in clinical trials and in a global postmarketing registry. British journal of haematology 190 (6) (2020)
David J Kuter, Fei Song, Elizabeth M Van Cott, David J Kuter, Rachel Rosovsky
Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19). American journal of hematology 95 (12) (2020)
David J Kuter, Donald M Arnold, Francesco Rodeghiero, Ann Janssens, Dominik Selleslag, Robert Bird, Adrian Newland, Jiri Mayer, Kejia Wang, Robert Olie
Safety and efficacy of self-administered romiplostim in patients with immune thrombocytopenia: Results of an integrated database of five clinical trials. American journal of hematology 95 (6) (2020)
Andrew B Song, David J Kuter, David J Kuter
Characterization of the rate, predictors, and thrombotic complications of thrombocytosis in iron deficiency anemia. American journal of hematology (2020)
David J Kuter, Adrian Newland, Beng H Chong, Francesco Rodeghiero, Monica T Romero, Ingrid Pabinger, Yuqi Chen, Kejia Wang, Bhakti Mehta, Melissa Eisen
Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies. British journal of haematology 185 (3) (2019)
David J Kuter, David J Kuter
Lactate dehydrogenase is elevated in immune thrombocytopenia and inversely correlates with platelet count. British journal of haematology 187 (3) (2019)
David J Kuter, David J Kuter
Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopenia. British journal of haematology 183 (2) (2018)
David J Kuter, Lee F Allen
Avatrombopag, an oral thrombopoietin receptor agonist: results of two double-blind, dose-rising, placebo-controlled Phase 1 studies. British journal of haematology 183 (3) (2018)